InflaRx NV
IFRX·Stocks·Biotechnology·Germany·Nasdaq·USD
Price
$2.02
Today
-5.8%
YTD
+117.2%
About
InflaRx is a biopharmaceutical company with international operations. The company discovers and develops inhibitors using C5a technology. It has headquarters in Jena, Germany, and was founded in 2007. The company's stock uses the IFRX ticker on the NASDAQ GS stock market. For more information and the latest updates on IFRX stock, be sure to add it to your eToro watchlist.
Price chart
Closing price history for IFRX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-1.96
P/S (TTM)654.49
P/B (TTM)3.49
Market cap$301.95M
Cap tierSmall-cap
Industry avg P/E-6.10
Profitability
Gross margin-457.26%
EBIT margin-33205.14%
Net margin-51452.32%
ROE-62.38%
ROA-54.58%
Earnings & Revenue
Revenue (TTM)$184,436.00
Revenue growth (1Y)+178.8%
EPS (TTM)-$1.05
Free cash flow$-51.68M
Total debt$948,292.86
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.15
Employees65
Next earnings9 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.